Ultragenyx Pharmaceutical | RARE - Capitalização De Mercado

Preço das Ações
19.87
Mudança Diária
-0.55 -2.69%
Mensal
-11.73%
Anual
-49.29%
Q1 Previsão
19.27




Capitalização De Mercado Alterar Data
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Agios Pharmaceuticals USD 1.59B 745M 2025-12
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
BioCryst Pharmaceuticals USD 1.7B 40M 2026-03
BioMarin Pharmaceutical USD 11.76B 348M 2026-03
Esperion Therapeutics USD 475M 410M 2026-03
Insmed USD 37.12B 6.68B 2025-12
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
Kyowa Hakko Kirin JPY 1.26T 64.41B 2026-03
MacroGenics USD 192M 90M 2026-03
Neurocrine Biosciences USD 14.14B 218M 2025-12
PTC Therapeutics USD 6.1B 1.22B 2025-12
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12